IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fairmount Funds Management LLC

Q1 2020 Holdings

Filed 2020-05-08 | 14 holdings | $46.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acadia Pharmaceuticals Inc(ACAD)COM004225108$25.5M603,51754.4%
Axsome Therapeutics Inc(AXSM)COM05464T104$11.2M189,59823.8%
Argenx SE(ARGX)SPONSORED ADR04016X101$10.1M76,63821.5%
Zogenix IncCOM NEW98978L204$24.0K971,8750.1%
Insmed Inc(INSM)COM PAR $.01457669307$16.4K1,020,7970.0%
Iovance Biotherapeutics Inc(IOVA)COM462260100$14.7K491,3900.0%
Amicus Therapeutics Inc(FOLD)COM03152W109$12.4K1,340,3950.0%
Karyopharm Therapeutics Inc(KPTIEUR)COM48576U106$10.8K562,3510.0%
Neoleukin Therapeutics IncCOM64049K104$9.2K810,0730.0%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$8.7K169,9490.0%
Allakos Inc(ALLKGUSD)COM01671P100$7.9K178,6620.0%
Trillium Therapeutics IncCOM NEW89620X506$7.3K1,818,1810.0%
Amarin Corp PLCSPONS ADR NEW023111206$3.5K871,7140.0%
Kiniksa Pharmaceuticals LTDCOM CL AG5269C101$3.1K200,1250.0%